CD8A and cancer: Furthermore, although the current study focused on the influences of DCIL-15-based cancer vaccines on CD8+ T cells, NK cells are also responsive to IL-15, and the impact of DCIL-15-based cancer vaccines on Type-1 NK cells needs to be comprehensively evaluated in future studies.